CSL Limited
CSL
Hisse Senetlerindeki Sıralama
#367
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Hisse Fiyatı
$136.26
Piyasa Değeri
$65.39B
Değişim (1 gün)
-0.61%
Değişim (1 yıl)
-4.06%
Ülke
AU
Ticaret CSL Limited (CSL)
Kategori
Healthcare
CSL Limited (CSL) için EPS
June 2026 itibariyle EPS TTM: $-5.29
CSL Limited şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $-5.29'dir. 2024 yılı sonunda, şirketin EPS'si $5.47 idi; bu, 2023 yılındaki EPS olan $4.55 ile önceki yıla göre artış.
CSL Limited için 2000 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
| Yıl | EPS | Değiştir |
|---|---|---|
| 2026 (TTM) | $-5.29 | -185.32% |
| 2025 | $6.20 | 13.35% |
| 2024 | $5.47 | 20.22% |
| 2023 | $4.55 | -31.37% |
| 2022 | $6.63 | 26.05% |
| 2021 | $5.26 | 13.61% |
| 2020 | $4.63 | 9.20% |
| 2019 | $4.24 | 50.89% |
| 2018 | $2.81 | -4.42% |
| 2017 | $2.94 | 9.29% |
| 2016 | $2.69 | -7.88% |
| 2015 | $2.92 | 8.15% |
| 2014 | $2.70 | 21.09% |
| 2013 | $2.23 | 12.45% |
| 2012 | $1.98 | -0.58% |
| 2011 | $1.99 | 49.05% |
| 2010 | $1.34 | 6.70% |
| 2009 | $1.25 | 7.16% |
| 2008 | $1.17 | 64.09% |
| 2007 | $0.71 | 500.34% |
| 2006 | $0.12 | -78.01% |
| 2005 | $0.54 | 168.22% |
| 2004 | $0.20 | 202.40% |
| 2003 | $0.07 | -21.18% |
| 2002 | $0.08 | -5.06% |
| 2001 | $0.09 | 83.13% |
| 2000 | $0.05 | 0.00% |
Benzer şirketler veya rakipler için EPS
| Şirket | EPS | EPS Farkı | Ülke |
|---|---|---|---|
| $17.32 | -427.41% |
US
|
|
| $-7.98 | 50.85% |
US
|
|
| - | - |
CH
|
|
| $27.74 | -624.39% |
NL
|
|
| $13.70 | -358.98% |
BE
|
